AMICUS THERAPEUTICS, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Amicus Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Amicus Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -69.5 %, a 52.9% increase year-over-year.
  • Amicus Therapeutics, Inc. annual Return On Equity for 2023 was -119 %, a 15.7% increase from 2022.
  • Amicus Therapeutics, Inc. annual Return On Equity for 2022 was -142 %, a 62.5% decline from 2021.
  • Amicus Therapeutics, Inc. annual Return On Equity for 2021 was -87.2 %, a 7.91% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -69.5 +78.1 +52.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -85.9 +71.9 +45.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -110 +43.9 +28.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -119 +22.3 +15.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -148 -23.7 -19.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -158 -55.3 -53.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -154 -58.6 -61.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -142 -54.5 -62.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -124 -39.3 -46.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -103 -8.36 -8.88% Apr 1, 2022 Jun 30, 2022
Q1 2022 -95.1 -11.8 -14.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -87.2 -6.39 -7.91% Oct 1, 2021 Dec 31, 2021
Q3 2021 -84.6 -8.94 -11.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -94.2 -28.7 -43.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -83.2 -19.1 -29.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -80.8 -12.2 -17.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -75.7 -4.7 -6.62% Jul 1, 2020 Sep 30, 2020
Q2 2020 -65.5 +32.4 +33.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -64.1 +30.8 +32.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -68.7 +7.32 +9.64% Oct 1, 2019 Dec 31, 2019
Q3 2019 -71 +2.67 +3.63% Jul 1, 2019 Sep 30, 2019
Q2 2019 -97.9 -34.5 -54.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -94.9 -23 -31.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -76 +8.79 +10.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -73.7 +7.52 +9.27% Jul 1, 2018 Sep 30, 2018
Q2 2018 -63.4 +2.02 +3.09% Apr 1, 2018 Jun 30, 2018
Q1 2018 -71.9 -8.93 -14.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -84.8 -25.2 -42.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -81.2 -25.8 -46.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -65.4 -14.3 -27.9% Apr 1, 2017 Jun 30, 2017
Q1 2017 -63 -18.7 -42.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -59.6 -14 -30.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -55.4 -8.11 -17.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -51.1 +8.89 +14.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -44.3 +56.8 +56.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 -45.6 +72.8 +61.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -47.3 +106 +69.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -60 +104 +63.5% Apr 1, 2015 Jun 30, 2015
Q1 2015 -101 +61.6 +37.9% Jan 1, 2015 Mar 31, 2015
Q4 2014 -118 +26 +18% Oct 1, 2014 Dec 31, 2014
Q3 2014 -153 -31.5 -25.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 -164 -65.4 -66.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -163 -84.7 -109% Jan 1, 2014 Mar 31, 2014
Q4 2013 -144 -79.4 -122% Oct 1, 2013 Dec 31, 2013
Q3 2013 -122 -48.9 -67% Jul 1, 2013 Sep 30, 2013
Q2 2013 -99 -24.7 -33.3% Apr 1, 2013 Jun 30, 2013
Q1 2013 -78 +14.2 +15.4% Jan 1, 2013 Mar 31, 2013
Q4 2012 -65.1 Oct 1, 2012 Dec 31, 2012
Q3 2012 -72.9 Jul 1, 2012 Sep 30, 2012
Q2 2012 -74.3 Apr 1, 2012 Jun 30, 2012
Q1 2012 -92.2 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.